Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2009 1
2011 1
2012 1
2013 1
2014 1
2015 1
2018 1
2020 0
Text availability
Article attribute
Article type
Publication date

Search Results

8 results
Results by year
Filters applied: . Clear all
Page 1
Your search for oncolytic Respiratory syncitial virus retrieved no results
Effect of respiratory syncytial virus on the growth of hepatocellular carcinoma cell-lines.
Choi SH, Park BK, Lee KW, Chang J, Lee Y, Kwon HJ. Choi SH, et al. BMB Rep. 2015 Oct;48(10):565-70. doi: 10.5483/bmbrep.2015.48.10.268. BMB Rep. 2015. PMID: 25739391 Free PMC article.
In several reports, the respiratory syncytial virus (RSV) was identified as an oncolytic virus in cancer cells (e.g., lung and prostate cancer). ...Therefore, further investigation is required to clarify the molecular mechanism of RSV-mediated i …
In several reports, the respiratory syncytial virus (RSV) was identified as an oncolytic virus in cancer …
TLR4-Based Immunotherapeutics in Cancer: A Review of the Achievements and Shortcomings.
Shetab Boushehri MA, Lamprecht A. Shetab Boushehri MA, et al. Mol Pharm. 2018 Nov 5;15(11):4777-4800. doi: 10.1021/acs.molpharmaceut.8b00691. Epub 2018 Oct 3. Mol Pharm. 2018. PMID: 30226786 Review.
Oncolytic targeting of androgen-sensitive prostate tumor by the respiratory syncytial virus (RSV): consequences of deficient interferon-dependent antiviral defense.
Echchgadda I, Chang TH, Sabbah A, Bakri I, Ikeno Y, Hubbard GB, Chatterjee B, Bose S. Echchgadda I, et al. BMC Cancer. 2011 Jan 28;11:43. doi: 10.1186/1471-2407-11-43. BMC Cancer. 2011. PMID: 21276246 Free PMC article.
BACKGROUND: Oncolytic virotherapy for cancer treatment utilizes viruses for selective infection and death of cancer cells without any adverse effect on normal cells. We previously reported that the human respiratory syncytial virus (RSV) is a no …
BACKGROUND: Oncolytic virotherapy for cancer treatment utilizes viruses for selective infection and death of cancer cells with …
Anticancer oncolytic activity of respiratory syncytial virus.
Echchgadda I, Kota S, DeLa Cruz I, Sabbah A, Chang T, Harnack R, Mgbemena V, Chatterjee B, Bose S. Echchgadda I, et al. Cancer Gene Ther. 2009 Dec;16(12):923-35. doi: 10.1038/cgt.2009.34. Epub 2009 May 15. Cancer Gene Ther. 2009. PMID: 19444304 Free PMC article.
Oncolytic virotherapy is an emerging biotherapeutic platform for cancer treatment, which is based on selective infection/killing of cancer cells by viruses. Herein we identify the human respiratory syncytial virus (RSV) as an oncolytic
Oncolytic virotherapy is an emerging biotherapeutic platform for cancer treatment, which is based on selective infection/killing of c
The Oncolytic Effect of Respiratory Syncytial Virus (RSV) in Human Skin Cancer Cell Line, A431.
Salimi V, Tavakoli-Yaraki M, Mahmoodi M, Shahabi S, Gharagozlou MJ, Shokri F, Mokhtari-Azad T. Salimi V, et al. Iran Red Crescent Med J. 2013 Jan;15(1):62-7. doi: 10.5812/ircmj.4722. Epub 2013 Jan 5. Iran Red Crescent Med J. 2013. PMID: 23487261 Free PMC article.
BACKGROUND: Oncolytic viruses have become of noticeable interest as a novel biological approach for selectively infecting cancer cells and triggering apoptosis in a number of malignant cells. Many researches are devoted to characterize more viruses with on
BACKGROUND: Oncolytic viruses have become of noticeable interest as a novel biological approach for selectively infecting canc …
Vesicular stomatitis virus as an oncolytic agent against pancreatic ductal adenocarcinoma.
Murphy AM, Besmer DM, Moerdyk-Schauwecker M, Moestl N, Ornelles DA, Mukherjee P, Grdzelishvili VZ. Murphy AM, et al. J Virol. 2012 Mar;86(6):3073-87. doi: 10.1128/JVI.05640-11. Epub 2012 Jan 11. J Virol. 2012. PMID: 22238308 Free PMC article.
In this study, the oncolytic potentials of several VSV variants were analyzed in a panel of 13 clinically relevant human PDA cell lines and compared to conditionally replicative adenoviruses (CRAds), Sendai virus and respiratory syncytial virus. …
In this study, the oncolytic potentials of several VSV variants were analyzed in a panel of 13 clinically relevant human PDA cell lin …
Inhibitors of the interferon response enhance virus replication in vitro.
Stewart CE, Randall RE, Adamson CS. Stewart CE, et al. PLoS One. 2014 Nov 12;9(11):e112014. doi: 10.1371/journal.pone.0112014. eCollection 2014. PLoS One. 2014. PMID: 25390891 Free PMC article.
This was demonstrated for a variety of viruses, including, viruses with disabled IFN antagonists that represent live-attenuated vaccine candidates (Respiratory Syncytial Virus (RSV), Influenza Virus), traditionally attenuated vaccine stra …
This was demonstrated for a variety of viruses, including, viruses with disabled IFN antagonists that represent live-attenuate …
Mechanistic analysis and comparison of viral fusogenic membrane proteins for their synergistic effects on chemotherapy.
Hoffmann D, Grunwald T, Kuate S, Wildner O. Hoffmann D, et al. Cancer Biol Ther. 2007 Apr;6(4):510-8. doi: 10.4161/cbt.6.4.3815. Cancer Biol Ther. 2007. PMID: 17374986 Retracted.
Previously we demonstrated that the expression of fusogenic membrane proteins (FMG) of measles virus (MV-H/F) can synergistically enhance chemotherapy. In this study, we used median-effect analysis to evaluate whether the expression of respiratory syncytial
Previously we demonstrated that the expression of fusogenic membrane proteins (FMG) of measles virus (MV-H/F) can synergistically enh …
Feedback